<code id='54AD09C350'></code><style id='54AD09C350'></style>
    • <acronym id='54AD09C350'></acronym>
      <center id='54AD09C350'><center id='54AD09C350'><tfoot id='54AD09C350'></tfoot></center><abbr id='54AD09C350'><dir id='54AD09C350'><tfoot id='54AD09C350'></tfoot><noframes id='54AD09C350'>

    • <optgroup id='54AD09C350'><strike id='54AD09C350'><sup id='54AD09C350'></sup></strike><code id='54AD09C350'></code></optgroup>
        1. <b id='54AD09C350'><label id='54AD09C350'><select id='54AD09C350'><dt id='54AD09C350'><span id='54AD09C350'></span></dt></select></label></b><u id='54AD09C350'></u>
          <i id='54AD09C350'><strike id='54AD09C350'><tt id='54AD09C350'><pre id='54AD09C350'></pre></tt></strike></i>

          hotspot

          hotspot

          author:explore    Page View:1
          The FDA building -- First Opinion coverage from STAT
          Adobe

          A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the medicine’s messy supporting data did not meet the standard for approval.

          After a day-long meeting that included impassioned testimony from ALS patients, the agency’s expert advisers voted 17-1 with one abstention that the case for NurOwn, a treatment from BrainStorm Cell Therapeutics, was based too heavily on convoluted clinical trial results and compelling but unreliable anecdotal evidence.

          advertisement

          “Patients and families need hope, but providing false hope can be ethically problematic,” said panelist Lisa Lee, a bioethicist at Virginia Tech. “False hope is provided when the probability of a positive outcome is overestimated, and I think that seems to be the case here.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Inari Medical to buy amputation prevention company LimFlow
          Inari Medical to buy amputation prevention company LimFlow

          Inariwillpay$250millionupfrontand$165moredependingonLimFlow’scommercialsuccess.DavidGregory&Debb

          read more
          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more

          Reports of telehealth's death have been greatly exaggerated

          Adobe“Telehealthiscollapsing.”“Telehealthisgoingthroughacontraction.”“Thereisadarkcloudhoveringoverv